Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
13,159,257
-
Share change
-
+3,012,263
-
Total reported value
-
$186,332,000
-
Price per share
-
$14.16
-
Number of holders
-
15
-
Value change
-
+$42,654,127
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of AMRYT PHARMA PLC - SPONSORED ADS (AMYT) as of Q4 2020
As of 31 Dec 2020,
AMRYT PHARMA PLC - SPONSORED ADS (AMYT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,159,257 shares.
The largest 10 holders included
Athyrium Capital Management, LP, EdgePoint Investment Group Inc., UBS OCONNOR LLC, Stonepine Capital Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Aquilo Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, Whitebox Advisors LLC, and ARMISTICE CAPITAL, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.